Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T-LPD

Pathology International

Volumn 58, Issue 4, 2008, Pages 209-217

  Ohshima, Koichi ^a   Kimura, Hiroshi ^b   Yoshino, Tadashi ^c   Kim, Chul Woo ^d   Ko, Young H ^e   Lee, Seung Suk ^f   Peh, Suat Cheng ^g   Chan, John K C ^h  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d Seoul National University College of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Korea Cancer Center Hospital   (South Korea)

^g UNIVERSITY OF MALAYA   (Malaysia)

^h QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

CAEBV; EBV; LPD; T NK cells

Indexed keywords

MONOCLONAL ANTIBODY; OLIGOCLONAL BAND; POLYCLONAL ANTIBODY;

CHRONIC ACTIVE EPSTEIN BARR VIRUS INFECTION; CLONAL VARIATION; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS ASSOCIATED NATURAL KILLER CELL LYMPHOPROLIFERATIVE DISORDER; FEVER; HEPATOSPLENOMEGALY; HUMAN; INFANTILE FULMINANT EPSTEIN BARR VIRUS ASSOCIATED NATURAL KILLER CELL LYMPHOPROLIFERATIVE DISEASE; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN MANIFESTATION; SYMPTOMATOLOGY; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS INFECTION; VIRUS INFECTIVITY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; T-LYMPHOCYTES;

EID: 40449101095     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02213.x     Document Type: Review

References (40)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964 i : 702 3.
2. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 1993 99 : 265 71.
3. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989 320 : 502 6.
4. Jaffe ES. Nasal and nasal-type NK/T cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 1995 27 : 581 3.
5. Hart DN, Baker BW, Inglis MJ et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 1992 79 : 2116 23.
6. Kawa K. Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease. Int J Hematol 2003 78 : 24 31.
7. Suzuki K, Ohshima K, Karube K et al. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 2004 24 : 1165 74.
8. Virelizier JL, Lenoir G, Griscelli C. Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet 1978 ii : 231 4.
9. Okano M, Kawa K, Kimura H et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005 80 : 64 9.
10. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 2006 16 : 251 61.
11. Coffey AJ, Brooksbank RA, Brandau O et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998 20 : 129 35.
12. Nichols KE, Harkin DP, Levitz S et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998 95 : 13 65 70.
13. Sayos J, Wu C, Morra M et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998 395 : 462 9.
14. Ma X, Okamura A, Yosioka M et al. No mutations of SAP/SH2D1a/DSHP and perforin genes in patients with Epstein-Barr virus associated hemophagocytic syndrome in Japan. J Med Virol 2001 65 : 358 61.
15. Kimura H, Hoshino Y, Kanegane H et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001 98 : 280 86.
16. Kimura H, Hoshino Y, Hara S et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 2005 191 : 531 9.
17. Su IJ, Lin DT, Hsieh HC et al. Fatal primary Epstein-Barr virus infection masquerading as histiocytic medullary reticulosis in young children in Taiwan. Hematol Pathol 1990 4 : 189 95.
18. Chen RL, Su IJ, Lin KH et al. Fulminant childhood hemophagocytic syndrome mimicking histocytic medullary reticulosis. Am J Clin Pathol 1991 96 : 171 6.
19. Su IJ, Chen RL, Lin DT et al. Epstein-Barr virus (EBV) infected T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994 144 : 1219 25.
20. Quintanilla-Martinez L, Kumar S, Fend F et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood 2000 96 : 443 51.
21. Kimura H, Morishima T, Kanegane H et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003 187 : 527 33.
22. Katano H, Ali MA, Patera AC et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 2004 103 : 1244 52.
23. Jones J, Shurin S, Abramowsky C et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988 318 : 733 41.
24. Kikuta H, Taguchi Y, Tomizawa K et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988 333 : 455 7.
25. Kawa-Ha K, Ishihara S, Ninomiya T et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989 84 : 51 5.
26. Kanegane H, Bhatia K, Gutierrez M et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood 1998 91 : 2085 91.
27. Kawa K, Okamura T, Yagi K et al. Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood 2001 98 : 3173 4.
28. Kasahara Y, Yachie A, Takei K et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001 98 : 1882 8.
29. Ohshima K, Suzumiya J, Sugihara M et al. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome. Pathol Int 1998 48 : 934 43.
30. Ohshima K, Suzumiya J, Ohga S et al. Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection. Int J Cancer 1997 71 : 943 7.
31. Kikuta H, Nakanishi M, Sakiyama Y, Matsumoto S. Chronic active Epstein-Barr virus (EBV) infection is associated with clonotypic intracellular terminal regions of the EBV. J Infect Dis 1989 160 : 546 7.
32. Ishihara S, Okada S, Wakiguchi H et al. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 1997 54 : 276 81.
33. Kanegane H, Wado T, Nunogami K et al. Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion. Br J Haematol 1996 95 : 116 22.
34. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 2002 44 : 283 94.
35. Toyabe S, Harada W, Uchiyama M. Biclonal expansion of T cells infected with monoclonal Epstein- Barr virus (EBV) in a patient with chronic, active EBV infection. Clin Exp Immunol 2003 134 : 92 7.
36. Endo R, Yoshioka M, Ebihara TI et al. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection. Med Hypotheses 2004 63 : 582 7.
37. Asano N, Suzuki R, Kagami Y et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 2005 29 : 1284 93.
38. Rickinson AB, Kieff E. Epstein-Barr virus. In : Knipe DM, Howly PM, eds. Virology, 4th edn, Vol. 2. Philadelphia, PA : Lippincott Williams & Wilkins, 2001 2575 627.
39. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000 343 : 481 92.
40. Sugaya N, Kimura H, Hara S et al. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. J Inf Dis 2004 190 : 985 8.